Yu Chengdong: Huawei WATCH   4 series watches will be launched to support hyperglycemia risk assessment study

Thanks to CTOnews.com netizen for the clue delivery of rain and snow! CTOnews.com May 15 news, Huawei Yu Chengdong Weibo said,"Huawei Watch will take the lead in supporting hyperglycemia risk assessment research, Huawei WATCH 4 series will be the first support." After people were authorized to participate in the study and wore the watch for a period of time, the watch informed them of their high blood sugar risk level, further drawing attention to healthy lifestyles. "Huawei WATCH 4 series will be unveiled at Huawei's new product launch on May 18. 

According to the poster, this product is not a medical device. The measurement data and results are for reference only and are not used as diagnosis and treatment basis. This function requires users to join the blood glucose health study initiated by a third-party professional medical institution. It is not applicable to users under the age of 18, type I diabetes mellitus, gestational diabetes mellitus and other special types of diabetes mellitus. For example, the hyperglycemia risk assessment can assess types over a week, such as moderate risk,"there may be short-term blood glucose fluctuations, excessive intake of high sugar, high oil and high fat diets may lead to increased risk of hyperglycemia," and users can click the button "Start a new round of assessment."

CTOnews.com has reported that Huawei WATCH 4 series flagship smart watch has been unveiled at the European launch conference. Huawei WATCH 4 Pro adopts 48mm titanium metal case, has 1.5-inch LTPO AMOLED display screen, covers sapphire glass, and weighs 48 grams. Comparatively, Huawei WATCH 4 is slightly smaller and has a 46mm stainless steel case.